4 completed. 4 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
| Phase 2 | 3 | Completed 3 |
Follow Critically Ill: new trials by email Literature Review of Critically Ill trials Research Report on Critically Ill
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Coated Devices to Decrease Infection in the Intensive Care Unit Coated devices, Control - Critically Ill | Phase 1 / Phase 2 | Completed | Hospital do Coracao | 103 | 2019-04-06 | 2020-03-09 |
| Plasma Pharmacokinetics (PK) & Lung Penetration of Ceftolozane/Tazobactam in Participants With Pneumonia (MK-7625A-007) Ceftolozane/Tazobactam - Multiple Doses, Ceftolozane/Tazobactam - Single Dose - Critically Ill, Pneumonia | Phase 1 | Completed | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 37 | 2015-02-05 | 2019-08-28 |
| TEAM: A Trial of Early Activity and Mobility in ICU Early mobilisation - Critically Ill | Phase 1 / Phase 2 | Completed | Australian and New Zealand Intensive Care Research Centre | 50 | 2013-08-01 | 2018-08-22 |
| The Use of Methadone in Newborn Infants Methadone - Premature Birth of Newborn, Critically Ill | Phase 1 / Phase 2 | Completed | John van den Anker | 60 | 2010-12-01 | 2018-07-26 |
Critical Illness (4) · Pneumonia (1) · Pneumonia, Ventilator-Associated (1) · Premature Birth (1) · Sepsis (1)
Disease Attributes (4) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Infections (2) · Lung Diseases (2) · Respiratory Tract Diseases (2) · Respiratory Tract Infections (2) · Cross Infection (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Healthcare-Associated Pneumonia (1) · Iatrogenic Disease (1) · Inflammation (1) · Obstetric Labor Complications (1) · Obstetric Labor, Premature (1) · Pneumonia (1)
Inulin (1) · Methadone (1) · Rehabilitation (1) · Tazobactam (1) · ceftolozane (1) · sinistrin (1)
Australian and New Zealand Intensive Care Research Centre (1) · Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (1) · Hospital do Coracao (1) · John van den Anker (1)
Australia (1) · Brazil (1) · New Zealand (1) · United States (1)
Alexandre Biasi, MD/PhD (1) · Carol L Hodgson, PhD (1)